Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05176288
Title Avelumab, Palbociclib and Axitinib in Advanced RCC (APART)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradley A. McGregor

renal cell carcinoma


Avelumab + Axitinib + Palbociclib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.